Serious Game to Teach Opioid Overdose Response
Launched by UNIVERSITY OF NEVADA, RENO · Dec 5, 2024
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to teaching students how to recognize and respond to opioid overdoses using a serious game. Opioid overdoses can be very dangerous, and this game aims to help students learn important skills in a fun and engaging way. The trial is currently not recruiting participants, but it will involve students enrolled in Health or Science classes at participating schools.
To be eligible for this trial, students must be part of a participating school and taking a relevant class. There are no specific exclusions, so anyone in this situation can potentially join. Participants can expect to play a serious game that teaches them how to identify the signs of an overdose and how to respond effectively. This innovative approach could make learning about a critical health issue more interactive and impactful.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Student at participating school, enrolled in Health or Science Class
- Exclusion Criteria:
- • None
About University Of Nevada, Reno
The University of Nevada, Reno, is a premier research institution dedicated to advancing health sciences through innovative clinical trials. With a commitment to excellence in research and education, the university leverages its multidisciplinary expertise to address pressing medical challenges. The institution fosters a collaborative environment that engages faculty, students, and community partners in the development and implementation of cutting-edge clinical studies. By prioritizing patient-centered research and adherence to rigorous ethical standards, the University of Nevada, Reno aims to contribute significantly to the advancement of medical knowledge and the improvement of healthcare outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported